HDAC9 and neoplasm: Several factors may cause the lack of HDAC response including low stability in the blood stream (two-hour elimination half-life) and an inability to accumulate adequate concentrations at the tumor site, a combination of increased drug efflux pump activity and low tumor penetration [26].